Companies: 10,795·Total market cap: $144.5T
DIAGNOS Inc.

DIAGNOS Inc.

ADK.VTSXVHealthcare● Active
$0.22
+$0.00(+0.00%)
Market Cap$21900540
P/E Ratio
52W High$0.42
52W Low$0.18

DIAGNOS Inc. (ADK.V) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

ADK.V · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026
EPS Actual
-$0.01
Revenue
$0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Jun 8, 2026
After Market Close
ADK.V reports quarterly as a TSXV-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q3 FY2026
Aug 20, 2026
EPS Actual
EPS Est.
-$0.01
EPS Surpr.
Revenue
Q2 FY2026
Jun 8, 2026
EPS Actual
-$0.01
EPS Est.
EPS Surpr.
Revenue
$0.00B
Q2 FY2026
Jun 8, 2026
EPS Actual
EPS Est.
-$0.01
EPS Surpr.
Revenue
Q2 FY2026
Jun 4, 2026
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q3 FY2025
Aug 20, 2025
EPS Actual
-$0.01
EPS Est.
EPS Surpr.
Revenue
$0.00B
Q2 FY2025
May 28, 2025Miss
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
-31.3%
Revenue
$0.00B
Q1 FY2025
Feb 12, 2025Miss
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
-29.4%
Revenue
$0.00B
Q4 FY2024
Nov 26, 2024
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
$0.00B

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
PeriodLowConsensusHigh# Analysts
Q1 FY2030$-0.01$-0.01$-0.011
Q4 FY2029$-0.01$-0.01$-0.011
Q3 FY2029$-0.01$-0.01$-0.011
Q2 FY2029$-0.02$-0.02$-0.021
Q1 FY2029$-0.01$-0.01$-0.011
Q4 FY2028$-0.01$-0.01$-0.011
Revenue Estimates
PeriodLowConsensusHigh# Analysts
Q1 FY2030$0.0B$0.0B$0.0B1
Q4 FY2029$0.0B$0.0B$0.0B1
Q3 FY2029$0.0B$0.0B$0.0B1
Q2 FY2029$0.0B$0.0B$0.0B1
Q1 FY2029$0.0B$0.0B$0.0B1
Q4 FY2028$0.0B$0.0B$0.0B1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.
Q2 FY2026+0.00%
Report Date
Jun 8, 2026
EPS Beat/Miss
Price Before
$0.22
Price After
$0.22
Q3 FY2025-1.92%
Report Date
Aug 20, 2025
EPS Beat/Miss
Price Before
$0.26
Price After
$0.26
Q2 FY2025-2.13%
Report Date
May 28, 2025
EPS Beat/Miss
-31.3%
Price Before
$0.24
Price After
$0.23
Q1 FY2025-3.08%
Report Date
Feb 12, 2025
EPS Beat/Miss
-29.4%
Price Before
$0.33
Price After
$0.32
Q4 FY2024+1.79%
Report Date
Nov 26, 2024
EPS Beat/Miss
+0.0%
Price Before
$0.28
Price After
$0.29
Q2 FY2024-1.69%
Report Date
Apr 11, 2024
EPS Beat/Miss
Price Before
$0.30
Price After
$0.29
Q1 FY2024-1.75%
Report Date
Feb 28, 2024
EPS Beat/Miss
+0.0%
Price Before
$0.29
Price After
$0.28
Q4 FY2023-2.70%
Report Date
Nov 28, 2023
EPS Beat/Miss
+0.0%
Price Before
$0.37
Price After
$0.36
Avg Beat Reaction-0.89%
Avg Miss Reaction-2.60%
Beat Rate3 / 8 quarters
Largest Move-3.08% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: ADK.V ends December

DIAGNOS Inc. (ADK.V) most recently reported earnings on June 8, 2026 for Q2 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —). The next ADK.V earnings date is expected around September 1, 2026.

Each quarter, investors track ADK.V earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ADK.V revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ADK.V's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

ADK.V earnings · 4 questions

DIAGNOS Inc.'s next earnings report is expected around September 1, 2026. ADK.V typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ADK.V historically reports after market close (AMC).

ADK.V earnings datewhen is ADK.V earningsADK.V next earnings datewhen does ADK.V report earningsADK.V earnings calendar

Source: FMP · DIAGNOS Inc. SEC filings · US GAAP · DIAGNOS Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026